ReviewAnnals of hematology2022

Increasing genomic discovery in newly diagnosed multiple myeloma: defining disease biology and its correlation to risk.

Patrick Hagen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.